4-tert-butyl-furan-2-carboxylic acid | 59414-09-4

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 呋喃
• 英文名称: 4-tert-butyl-furan-2-carboxylic acid
• 英文别名: 4-tert-Butyl-furan-2-carbonsaeure；tert-butyl-furan-2-carboxylic acid；4-Tert-butyl-furan-2-carboxylic acid；4-tert-butylfuran-2-carboxylic acid
• CAS: 59414-09-4
• 化学式: C₉H₁₂O₃
• 分子量: 168.192
• InChiKey: AGVWRIQQQWFTBZ-UHFFFAOYSA-N

物化性质

• 熔点：
  89 °C
• 沸点：
  260.8±28.0 °C(Predicted)
• 密度：
  1?+-.0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2.5
• 重原子数：
  12
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.44
• 拓扑面积：
  50.4
• 氢给体数：
  1
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  4-tert-butyl-furan-2-carboxylic acid 、 3-氨基苯基苯甲酮 在 polymer-bound EDC 作用下， 生成 4-tert-Butyl-furan-2-carboxylic acid (3-benzoyl-phenyl)-amide
  参考文献：
  名称：

  Utility of Complementary Molecular Reactivity and Molecular Recognition (CMR/R) Technology and Polymer-Supported Reagents in the Solution-Phase Synthesis of Heterocyclic Carboxamides

  摘要：

  The use of our recently reported chemical library purification strategy in the development of a herbicidal lead, N-(3-benzoylphenyl)-3-(1,1-dimethylethyl)-1-methyl-1H-pyrazole-5-carboxamide (3), is described. The approach applying fundamental properties of complementary molecular reactivity and molecular recognition (CMR/R) as the basis for a general purification strategy was utilized. Polymeric reagents were used in the synthesis to generate reactive species involved in product formation, and complementary molecular reactivity/molecular recognition polymer 8 (CMR/R polymer 8) was used in the solution-phase syntheses of building blocks, primary libraries, and lead refinement libraries. An extension of the CMR/R methodology was applied, utilizing a sequestration enabling reagent (SER), transforming a reactant into an electrophilic species sequestrable by CMR/R polymer 8. This library purification strategy enabled rapid lead generation and lead refinement to afford herbicide 27o. The CMR/R solid-phase purification technique enabled a simple, general, and powerful protocol, eliminating the usual tedious and time-consuming methods required for solution-phase product purification. The result was the synthesis of hundreds of compounds, prepared in a relatively short time, leading to a compound with a 4-fold improvement in herbicidal activity over the initial lead.

  DOI：

  10.1021/jo970571i
• 作为产物：
  描述：

  5-溴-2-糠酸甲酯 在 aluminum (III) chloride 氨 、 水 、 sodium hydroxide 、 锌 作用下， 以 四氢呋喃 、 甲醇 、 二硫化碳 、 水 为溶剂， 反应 16.0h， 生成 4-tert-butyl-furan-2-carboxylic acid
  参考文献：
  名称：

  SUBSTITUTED AZA-BICYCLIC IMIDAZOLE DERIVATIVES USEFUL AS TRPM8 RECEPTOR MODULATORS

  摘要：

  本发明涉及替代的氮杂双环咪唑衍生物，含有它们的药物组合物以及它们在治疗由TRP M8调节的疾病和症状中的用途，包括但不限于炎症性疼痛、炎症性过敏症、炎症性过敏性疾病、神经病性疼痛、神经性寒冷痛觉过敏、炎症性体感过敏、炎症性内脏过敏、受寒加重的心血管疾病和受寒加重的肺部疾病。

  公开号：

  US20110218197A1
• 作为试剂：
  描述：

  氨 、 5-bromo-4-tert-butyl-furan-2-carboxylic acid 在 锌 4-tert-butyl-furan-2-carboxylic acid 作用下， 生成 4-tert-butyl-furan-2-carboxylic acid
  参考文献：
  名称：

  SUBSTITUTED AZA-BICYCLIC IMIDAZOLE DERIVATIVES USEFUL AS TRPM8 RECEPTOR MODULATORS

  摘要：

  本发明涉及取代的氮杂双环咪唑衍生物、含有它们的药物组合物以及它们在治疗由TRP M8调节的疾病和病症中的应用，例如炎症性疼痛、炎症性过敏症、炎症性过敏性疾病、神经病理性疼痛、神经性冷痛觉、炎症性体表过敏症、炎症性内脏过敏症、由寒冷加重的心血管疾病和由寒冷加重的肺部疾病。

  公开号：

  US20150158875A1

文献信息

• 3,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands
  申请人：Taveras G. Arthur

  公开号：US20070021494A1

  公开（公告）日：2007-01-25

  There are disclosed compounds of the formula or a pharmaceutically acceptable salt or solvate thereof which are useful for the treatment of chemokine-mediated diseases such as acute and chronic inflammatory disorders and cancer.

  公开了以下化合物的公式或其药学上可接受的盐或溶剂，它们可用于治疗趋化因子介导的疾病，如急性和慢性炎症性疾病和癌症。
• 3,4-Di-Substituted Cyclobutene-1,2-Diones as CXC-Chemokine Receptor Ligands
  申请人：Taveras Arthur G.

  公开号：US20110213029A1

  公开（公告）日：2011-09-01

  There are disclosed compounds of the formula or a pharmaceutically acceptable salt or solvate thereof which are useful for the treatment of chemokine-mediated diseases such as acute and chronic inflammatory disorders and cancer.

  公开了以下式的化合物，或其药学上可接受的盐或溶剂，它们可用于治疗由趋化因子介导的疾病，如急性和慢性炎症性疾病和癌症。
• Substituted aza-bicyclic imidazole derivatives useful as TRPM8 receptor modulators
  申请人：Player Mark R.

  公开号：US08680098B2

  公开（公告）日：2014-03-25

  The present invention is directed to substituted aza-bicyclic imidazole derivatives, pharmaceutical compositions containing them and their use in the treatment of disorders and conditions modulated by TRP M8, including for example, inflammatory pain, inflammatory hyperalgesia, inflammatory hypersensitivity condition, neuropathic pain, neuropathic cold allodynia, inflammatory somatic hyperalgesia, inflammatory visceral hyperalgesia, cardiovascular disease aggravated by cold and pulmonary disease aggravated by cold.

  本发明涉及替代的氮杂双环咪唑衍生物、包含它们的制药组合物以及它们在治疗受TRP M8调节的疾病和症状中的应用，包括但不限于炎症性疼痛、炎症性过敏症、炎症性过敏症状、神经病性疼痛、神经病性冷痛觉、炎症性体表过敏症、炎症性内脏过敏症、受寒冷加重的心血管疾病和受寒冷加重的肺部疾病。
• Substituted AZA-bicyclic imidazole derivatives useful as TRPM8 receptor modulators
  申请人：Janssen Pharmaceutica, NV

  公开号：US09023846B2

  公开（公告）日：2015-05-05

  The present invention is directed to substituted aza-bicyclic imidazole derivatives, pharmaceutical compositions containing them and their use in the treatment of disorders and conditions modulated by TRP M8, including for example, inflammatory pain, inflammatory hyperalgesia, inflammatory hypersensitivity condition, neuropathic pain, neuropathic cold allodynia, inflammatory somatic hyperalgesia, inflammatory visceral hyperalgesia, cardiovascular disease aggravated by cold and pulmonary disease aggravated by cold.

  本发明涉及取代的氮杂双环咪唑衍生物，包含它们的制药组合物以及它们在治疗TRP M8调节的疾病和病症中的应用，例如炎症性疼痛、炎症性过敏症、炎症性过敏性症状、神经病性疼痛、神经病性冷痛觉过敏、炎症性体表过敏症、炎症性脏器过敏症、寒冷加重的心血管疾病和寒冷加重的肺部疾病。
• Cystobactamide derivatives
  申请人：HELMHOLTZ-ZENTRUM FÜR INFEKTIONSFORSCHUNG GMBH

  公开号：US11034648B2

  公开（公告）日：2021-06-15

  The present invention relates to novel derivatives of cystobactamides of formula (Ib) and the use thereof for the treatment or prophylaxis of bacterial infections.

  本发明涉及式（Ib）胱内酰胺的新型衍生物及其在治疗或预防细菌感染中的应用。